Socioeconomic disparities in breast cancer treatment among older women

Journal of Women's Health

Volumn 23, Issue 4, 2014, Pages 335-341

  White, Arica ^a   Richardson, Lisa C ^a   Krontiras, Helen ^b   Pisu, Maria ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CAUCASIAN; CONTROLLED STUDY; FEMALE; HEALTH CARE DISPARITY; HIGH SCHOOL STUDENT; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; MULTIMODALITY CANCER THERAPY; NEGRO; PARTIAL MASTECTOMY; POVERTY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS; TREATMENT DURATION; TUMOR VOLUME; UNDERGRADUATE STUDENT; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALABAMA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; MASTECTOMY; MEDICARE; NEOPLASM STAGING; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; SOCIAL CLASS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84898013669     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4460     Document Type: Article

References (41)

1. U.S. Cancer Statistics Working Group. United States cancer statistics: 1999-2009 incidence and mortality web-based report. 2013. Available at: www.cdc.gov/uscs Accessed January 31, 2013.
2. van Ravesteyn NT, Schechter CB, Near AM, et al. Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev 2011;20:112-122.
3. Goodwin JS, Hunt WC, Samet JM. Determinants of cancer therapy in elderly patients. Cancer 1993;72:594-601.
4. Fisher B, Anderson S, Redmond CK, Wolmark N,Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1461.
5. National Institutes of Health (NIH). Treatment of early-stage breast cancer. NIH Consnsus Development Conference consensus statement, June 18-21, 1990. JAMA 1991;265:391-395.
6. Alderman AK, Bynum J, Sutherland J, Birkmeyer N, Collins ED, Birkmeyer J. Surgical treatment of breast cancer among the elderly in the United States. Cancer 2011;117:698-704.
7. Lantz PM, Janz NK, Fagerlin A, et al. Satisfaction with surgery outcomes and the decision process in a populationbased sample of women with breast cancer. Health Serv Res 2005;40:745-767.
8. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: Breast cancer. Fort Washington, PA: NCCN, 2005.
9. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002? Cancer 2008;112:900-908.
10. Keating NL, Kouri E, He Y, Weeks JC, Winer EP. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 2009;47:765-773.
11. Sail K, Franzini L, Lairson D, Du X. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Ethn Health 2012;17:309-323.
12. Worthington J, Waterbor JW, Funkhouser E, Falkson C, Cofield S, Fouad M. Receipt of standard breast cancer treatment by African American and White women. Int J Med Sci 2008;5:181-188.
13. Lipscomb J, Gillespie TW, Goodman M, et al. Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat 2012;133:285-296.
14. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:IV-3-18.
15. U.S. Census Bureau: State and County QuickFacts. 2011. Available at: http://quickfacts.census.gov/qfd/states/01000.html
16. Ballas LK, Elkin EB, Schrag D, Minsky BD, Bach PB. Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys 2006;66:1204-1211.
17. American Medical Association. Physicians' current procedural terminology-CPT 2000. Chicago, IL: American Medical Association, 2000.
18. Health Care Financing Administration. HCFA common procedure coding system (HCPCS): National level II medicare codes. Los Angeles, CA: Practice Management Information Corporation, 2000.
19. U.S. Public Health Services. International classification of diseases, 9th revision. Clinical modification, 5th ed. Los Angeles, CA: Practice Management Information Corporation, 1996.
20. Alabama Department of Public Health Office of Primary Care and Rural Health: Indicators of health status in Alabama: Cancer mortality. 2007. Available at www.adph.org/ruralhealth/Default.asp?id = 1798, 2012.
21. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. Clin Epidemiol 2000;53:1258-1267.
22. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: How much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 2008;112:171-180.
23. Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis 2007;17:122-128.
24. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-1427.
25. Srokowski TP, Fang S, Duan Z, et al. Completion of adjuvant radiation therapy among women with breast cancer. Cancer 2008;113:22-29.
26. Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006;24:2750-2756.
27. Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: Findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008;113:582-591.
28. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002;94:490-496.
29. Voti L, Richardson LC, Reis IM, Fleming LE, Mackinnon J, Coebergh JW. Treatment of local breast carcinoma in Florida: The role of the distance to radiation therapy facilities. Cancer 2006;106:201-207.
30. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005;23:5526-5533.
31. Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB. Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 2002;40:181-189.
32. Smith GL, Xu Y, Shih YC, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg 2009;209:425-433, e422.
33. Singh GK, Miller BA, Hankey BF, BK. E. Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD: National Cancer Institute, 2003.
34. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000;92:269-271.
35. U.S. Census Bureau. Statistical abstract of the United States: 2012 (131st Edition). Washington, DC: 2011. Available at: www.census.gov/compendia/ statab
36. Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences. Cancer 2000;89:561-573.
37. Bhargava A, Du XL. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph nodepositive, operable breast cancer. Cancer 2009;115:2999-3008.
38. Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006;98: 681-690.
39. Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care 2006;44:124-131.
40. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241.
41. Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer. Semin Oncol 2010;37:384-401.